PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31852219-3	2020	We, and others, previously demonstrated that microRNA-144 (miR-144) functions to post-transcriptionally regulate ABCA1 (ATP binding cassette transporter A1) and plasma HDL (high-density lipoprotein) cholesterol levels.	Cholesterol	199-210	microRNA 144	Mus musculus	45-57	
31852219-3	2020	We, and others, previously demonstrated that microRNA-144 (miR-144) functions to post-transcriptionally regulate ABCA1 (ATP binding cassette transporter A1) and plasma HDL (high-density lipoprotein) cholesterol levels.	Cholesterol	199-210	microRNA 144	Mus musculus	59-66	
31852219-6	2020	MiR-144 antagonism increased circulating HDL cholesterol levels, remodeled the HDL particle, and enhanced reverse cholesterol transport.	Cholesterol	45-56	microRNA 144	Mus musculus	0-7	
31852219-6	2020	MiR-144 antagonism increased circulating HDL cholesterol levels, remodeled the HDL particle, and enhanced reverse cholesterol transport.	Cholesterol	114-125	microRNA 144	Mus musculus	0-7	
31852219-7	2020	Notably, the effects on HDL and reverse cholesterol transport were more pronounced in male mice suggesting sex-specific differences may contribute to the effects of silencing miR-144 on atherosclerosis.	Cholesterol	40-51	microRNA 144	Mus musculus	175-182	
31852219-8	2020	As a molecular mechanism, we identify the oxysterol metabolizing enzyme CYP7B1 (cytochrome P450 enzyme 7B1) as a miR-144 regulated gene in male, but not female mice.	arthrofactin	42-51	cytochrome P450, family 7, subfamily b, polypeptide 1	Mus musculus	72-78	
31852219-8	2020	As a molecular mechanism, we identify the oxysterol metabolizing enzyme CYP7B1 (cytochrome P450 enzyme 7B1) as a miR-144 regulated gene in male, but not female mice.	arthrofactin	42-51	cytochrome P450, family 7, subfamily b, polypeptide 1	Mus musculus	80-106	
31852219-8	2020	As a molecular mechanism, we identify the oxysterol metabolizing enzyme CYP7B1 (cytochrome P450 enzyme 7B1) as a miR-144 regulated gene in male, but not female mice.	arthrofactin	42-51	microRNA 144	Mus musculus	113-120	
31852219-9	2020	Consistent with miR-144-dependent changes in CYP7B1 activity, we show decreased levels of 27-hydroxycholesterol, a known proatherogenic sterol and the endogenous substrate for CYP7B1 in male, but not female mice.	Hydroxycholesterols	93-111	microRNA 144	Mus musculus	16-23	
31852219-9	2020	Consistent with miR-144-dependent changes in CYP7B1 activity, we show decreased levels of 27-hydroxycholesterol, a known proatherogenic sterol and the endogenous substrate for CYP7B1 in male, but not female mice.	Sterols	105-111	microRNA 144	Mus musculus	16-23	
31852219-9	2020	Consistent with miR-144-dependent changes in CYP7B1 activity, we show decreased levels of 27-hydroxycholesterol, a known proatherogenic sterol and the endogenous substrate for CYP7B1 in male, but not female mice.	Sterols	105-111	cytochrome P450, family 7, subfamily b, polypeptide 1	Mus musculus	45-51	
31852219-9	2020	Consistent with miR-144-dependent changes in CYP7B1 activity, we show decreased levels of 27-hydroxycholesterol, a known proatherogenic sterol and the endogenous substrate for CYP7B1 in male, but not female mice.	Sterols	105-111	cytochrome P450, family 7, subfamily b, polypeptide 1	Mus musculus	176-182	
31852219-10	2020	CONCLUSIONS: Our data demonstrate silencing miR-144 has sex-specific effects and that treatment with antisense oligonucleotides to target miR-144 might result in enhancements in reverse cholesterol transport and oxysterol metabolism in patients with cardiovascular disease.	Cholesterol	186-197	microRNA 144	Homo sapiens	44-51	
31852219-10	2020	CONCLUSIONS: Our data demonstrate silencing miR-144 has sex-specific effects and that treatment with antisense oligonucleotides to target miR-144 might result in enhancements in reverse cholesterol transport and oxysterol metabolism in patients with cardiovascular disease.	Cholesterol	186-197	microRNA 144	Homo sapiens	138-145	
31852219-10	2020	CONCLUSIONS: Our data demonstrate silencing miR-144 has sex-specific effects and that treatment with antisense oligonucleotides to target miR-144 might result in enhancements in reverse cholesterol transport and oxysterol metabolism in patients with cardiovascular disease.	arthrofactin	212-221	microRNA 144	Homo sapiens	138-145